It has been reported that ATRA affects the growth and proliferation of cancer cells by affecting MAPK, mammalian target of Rapamycin (mTOR) and indirectly phosphatidylinositol-3-kinase (PI3K)/Akt pathways (Giuli et al. 2020). The gene discussed is AKT1; the disease is cancer.